Inflammatory and metabolic changes of severe obese women after 6 months of a Roux‐en‐Y gastric bypass

Abstract only Obesity is a chronic disease related to adipokines production, which contribute to inflammation and metabolic abnormalities. The Roux‐en‐Y gastric bypass is an alternative therapy for the treatment of severe obesity, reaching weight loss superior to conventional therapies. The aim was...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal Vol. 26; no. S1
Main Authors: Pierine, Damiana Tortolero, Biagioni, Maria F., Calvi, Sueli A., Mendes, Adriana L., Paiva, Sérgio A. R., Leite, Celso V., Mazeto, Gláucia M. F. S., Corrêa, Camila R.
Format: Journal Article
Language:English
Published: 01-04-2012
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract only Obesity is a chronic disease related to adipokines production, which contribute to inflammation and metabolic abnormalities. The Roux‐en‐Y gastric bypass is an alternative therapy for the treatment of severe obesity, reaching weight loss superior to conventional therapies. The aim was observed the inflammatory and metabolic changes after 6 months of Roux‐en‐Y gastric bypass. Nine women aged 24 – 48 years old, BMI > 35 kg/m 2 (50.9±9.6), submitted to Roux‐en‐Y gastric bypass. Plasma concentrations evaluated: glucose (mg/dL), leptin (pg/mL), adiponectin (ng/mL), TNF‐α (pg/mL) and IL‐6 (pg/mL). Anthropometric assessment: weight (kg), BMI (kg/m2) and fat mass (FM: kg). We observed reduction in body weight (130.1±23.8 × 98.5±25.2, p<0.01) and FM (72.1±17.4 × 40.8±8.3, p<0.01). Significant metabolic changes were found, such as reduction in leptin [431.3 (303.8 – 532.2) × 96.7 (62.0 – 176.8), p<0.01] and glucose [97.0 (84.5 – 107.5) × 82.0 (74.7 – 85.0), p=0.04] and increased adiponectin (62.7±21. 2 × 206.0±120.8, p<0.01). With respect to pro‐inflammatory parameters, no significant changes were observed in TNF‐α (0.44±0.69 × 0.3±0.5, p=0.20) and IL‐6 [4.7 (3.2 – 7.6) × 1.8 (0.9 – 3.8), p=0.12]. Six months after surgery decreased fat mass and resulting in changes as decreased leptin and glucose and increased adiponectin. In other hand in this period there was no change in inflammatory parameters.
ISSN:0892-6638
1530-6860
DOI:10.1096/fasebj.26.1_supplement.lb418